Enovis (ENOV) Share-based Compensation (2010 - 2026)
Enovis' (ENOV) quarterly Share-based Compensation came in at $8.8 million in Q2 2026, up 153.84% year-on-year from $3.4 million in Q2 2025, and down 80.3% on a QoQ basis from $44.4 million in Q4 2025.
Enovis (ENOV) Share-based Compensation (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Share-based Compensation data on file, last reported at $8.8 million in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 153.84% year-over-year to $8.8 million in Q2 2026; TTM through Apr 2026 was $49.7 million, a 75.43% increase from a year earlier, with the FY2025 full-year figure at $44.4 million, up 49.72% from the prior year.
- Share-based Compensation for Q2 2026 stood at $8.8 million, down from $44.4 million in the prior quarter.
- Over the last five years, Share-based Compensation for ENOV reached as high as $103.1 million in Q2 2024 and fell as low as -$85.9 million in Q3 2024.
- Historically, Share-based Compensation has averaged $5.5 million across 5 years, with a median of $7.7 million in 2024.
- Across the five-year window, Share-based Compensation slumped 108.43% in 2023 and soared 12403.7% in 2024, its largest moves.
- Year by year, Share-based Compensation stood at -$27.8 million in 2022, then jumped by 96.99% to -$838000.0 in 2023, then surged by 1022.91% to $7.7 million in 2024, then surged by 474.22% to $44.4 million in 2025, then tumbled by 80.3% to $8.8 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $8.8 million in Q2 2026, $44.4 million in Q4 2025, and -$16.1 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 8.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 8.75 Mn |
| Apr 3, 2026 | 8.75 Mn |
| Dec 31, 2025 | 44.41 Mn |
| Dec 31, 2025 | 44.41 Mn |
| Oct 3, 2025 | -16.08 Mn |
| Oct 3, 2025 | -16.08 Mn |
| Jul 4, 2025 | 12.63 Mn |
| Jul 4, 2025 | 12.63 Mn |
| Apr 4, 2025 | 3.45 Mn |
| Apr 4, 2025 | 3.45 Mn |
| Dec 31, 2024 | 7.73 Mn |
| Dec 31, 2024 | 7.73 Mn |
| Sep 27, 2024 | -85.95 Mn |
| Sep 27, 2024 | -85.95 Mn |
| Jun 28, 2024 | 103.11 Mn |
| Jun 28, 2024 | 103.11 Mn |
| Mar 29, 2024 | 4.77 Mn |
| Mar 29, 2024 | 4.77 Mn |
| Jun 30, 2023 | -838,000.00 |
| Jun 30, 2023 | -838,000.00 |